(DOCRF) –
-
CloudMD Reports Third Quarter 2023 Financial Results; Company Delivers Early on Commitment to be Adjusted EBITDA Positive
-
CloudMD Announces Third Quarter Earnings Date
-
CloudMD to Present at TD Securities 2023 Technology Conference
-
CloudMD Provides Update on Growing Momentum Driven by Client Demand for Navigated Healthcare Solutions & Increased Operational Efficiencies
-
CloudMD at the Association of Family Health Team (AFHTO) Conference to Showcase Positive Patient Mental Health Outcomes from Innovative Programs
-
CloudMD Invites Investors to Attend Upcoming Investor Day
-
CloudMD Reports Second Quarter 2023 CloudMD Continues to Drive Execution with Adjusted EBITDA Approaching Breakeven
-
CloudMD to Report First Quarter Financial Results on Monday, May 29, 2023
-
CloudMD and XTM Bring EAP and Telemedicine to the Service Industry
-
CloudMD Reports 2022 Results for the Full Year and Fourth Quarter
-
CloudMD to Report Fourth Quarter Financial Results on Monday, April 24, 2023
-
CloudMD Expands Partnership with Benefits Alliance to Include Full Suite of Kii Services
-
CloudMD Names Dhruv Chandra Chief Technology Officer to Accelerate Technological Advancement in Next Phase of Growth
-
CloudMD Suite of Services Available to Canadian Hospitals through Mohawk Medbuy
-
CloudMD Expands Health Care Navigation to Vision Care with Launch of Online Prescription Renewals in the United States
-
Bram Lowsky joins CloudMD as new Head of Health and Wellness Services (formerly Enterprise Health Solutions)
-
CloudMD to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
-
CloudMD Study Uncovers why Employees are not Utilizing Employer-Paid Health & Wellness Benefits when Stress and Burnout are at Record Levels
-
CloudMD Makes Mental Health More Accessible with Launch of Spanish Language TAiCBT in the United States
-
CloudMD Closes Divestment of Pharmacies to Neighbourly Pharmacy
-
CloudMD Announces Results of 2022 AGM
-
CloudMD Announces Filing of Management Information Circular for Annual and Special Meeting of Shareholders
-
CloudMD to Present at Upcoming TD Technology Conference, November 21 – 23, 2022
-
CloudMD Reports Third Quarter 2022 Financial Performance
-
CloudMD to Report Third Quarter Financial Results on Monday, November 14, 2022
-
CloudMD Closes Divestment of Primary Care Clinics and Cloud Practice to WELL Health
-
CloudMD Announces Divestment of Pharmacies to Neighbourly Pharmacy
-
CloudMD Announces Divestment of Primary Care Clinics and Cloud Practice to WELL Health
-
CloudMD’s TAiCBT Results in Significant Improvement for PTSD Across Symptom Severity Levels, Trauma Types and Demographics
-
Canaccord Genuity Reiterates Hold Rating on CloudMD Software & Services Inc (DOC:CN) (DOCRF)
-
CloudMD Reports Q2 2022 Financial Performance; New Leadership Enforces Strategic Priorities to Drive Further Cost Optimization and Profitability
-
CloudMD to Report Second Quarter Financial Results on Monday, August 22, 2022
-
Canaccord Genuity Downgrades CloudMD Software & Services Inc (DOC:CN) (DOCRF) to Hold
-
CloudMD Provides Business Update on Customer Momentum
-
CloudMD Appoints Karen Adams as Chief Executive Officer and John Plunkett as Chief Financial Officer
-
CloudMD Finalizes Review and Settlement of the VisionPros Acquisition
-
CloudMD Adds Telemedicine Services for Primary Care Health Navigation to Kii Personalized & Connected Care Offering
-
CloudMD Provides Update on Strategic Priorities to Drive Organic Growth Through New Sales and Cross Selling
-
CloudMD Reports Results of Evidence Based Study Proving iCBT as Highly Effective Treatment for Depression and Anxiety
-
CloudMD Reports First Quarter 2022 Financial Performance with Clear Path to Profitability and Strong Roadmap for Growth
-
CloudMD Launches Kii Personalized & Connected Care, the New Brand Identity for its Transformational Integrated Health Services Offering
-
CloudMD to Report First Quarter Financial Results on Monday, May 30, 2022
-
CloudMD Reports Solid Performance with Fourth Quarter 2021 Financial Results; Revenue of $38.7 Million and Second Consecutive Quarter with Positive Adjusted EBITDA
-
CloudMD Announces May 3, 2022 as Revised Date for Fourth Quarter and Full Year 2021 Earnings Call
-
CloudMD Strengthens Board with Appointment of Gaston Tano as Director
-
CloudMD to Release Fourth Quarter and Year-End Financial Results on May 2, 2022
-
CloudMD Announces Resignation of Director
-
Canaccord Genuity Reiterates Spec. Buy Rating on CloudMD Software & Services Inc (DOC:CN) (DOCRF)
-
CloudMD Announces CEO Succession
-
Canaccord Genuity Reiterates Spec. Buy Rating on CloudMD Software & Services Inc (DOC:CN) (DOCRF)
Back to DOCRF Stock Lookup
